Cited by 36Bacterial Infections and VaccinesHealth Systems, Economic Evaluations, Quality of LifeLife Cycle Costing Analysis

The DOI matches its Crossref record, with a small difference in title or year; 1 of the 1 references it cites were found in a registry or an index.

Counting the Cost of Meningococcal Disease: Scenarios of Severe Meningitis and Septicemia

Abstract

Background Meningococcal disease can result in severe disabling sequelae, but there is no published information about the lifelong rehabilitation costs of patients with severe outcome in the UK. As cost-effectiveness studies play a crucial role in determining whether immunization programmes will be implemented, it is important to identify these costs. Objective The aim of the study was to estimate lifelong rehabilitation costs associated with severe cases of meningococcal disease and to present these costs in a format appropriate for use in a cost-effectiveness analysis. Methods Two severe scenarios of meningococcal disease with major sequelae were developed; one that presented acutely as meningitis and the other as septicemia. Scenarios were based on systematic reviews of the literature describing the sequelae of meningococcal disease, dialogue with Meningitis Research Foundation members who have experience of the disease, and discussions with pediatricians who have been responsible for managing children with this disease over many years. The two scenarios were devised to represent cases typical of the severe end of the spectrum. To obtain a comprehensive list of the health, educational and other resources used by survivors during and since their acute illness, families of individuals with sequelae similar to those in each of our scenarios were interviewed. Relevant academics and professionals in health, social care and education were consulted in order to ensure that our sc…

Overview

Integrity signals

Registry

Crossref · 10.1007/s40272-012-0006-0

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 1 references

Research works printed but not linked: 11

  1. Erickson L, De Wals P. Complications and sequelae of meningococcal disease in Quebec, Canada, 1990–1994. Clin Infect Dis. 1998;26(5):1159–64. · DOI
  2. Canavese F, Krajbich JI, LaFleur BJ. Orthopaedic sequelae of childhood meningococcemia: management considerations and outcome. J Bone Joint Surg Am. 2010;92(12):2196–203. · DOI
  3. Hall AJ. The United Kingdom Joint Committee on Vaccination and Immunisation. Vaccine. 2010;28(Suppl 1):A54–7. · DOI
  4. Trotter CL, Edmunds WJ. Modelling cost effectiveness of meningococcal serogroup C conjugate vaccination campaign in England and Wales. BMJ. 2002;324:809. · DOI
  5. Ten Jonsson B. Arguments for a societal perspective in the economic evaluation of medical innovations. Eur J Health Econ. 2009;10(4):357–9. · DOI
  6. Treasury HM. The green book: appraisal and evaluation in central government. London: TSO; 2003.
  7. Buysse CM, et al. Long-term health status in childhood survivors of meningococcal septic shock. Arch Pediatr Adolesc Med. 2008;162(11):1036–41. · DOI
  8. Welte R, et al. The role of economic evaluation in vaccine decision making: focus on meningococcal group C conjugate vaccine. Pharmacoeconomics. 2005;23(9):855–74. · DOI
  9. Gordon D, Parker R, Loughran F, Heslop P. Disabled children in Britain: a re-analysis of the OPCS disability survey. London: The Stationery Office; 2000.
  10. Cadman D, Boyle M, Offord DR. The Ontario Child Health Study: social adjustment and mental health of siblings of children with chronic health problems. J Dev Behav Pediatr. 1988;9(3):117–21. · DOI
  11. Viner RM, et al. Outcomes of invasive meningococcal serogroup B disease in children and adolescents (MOSAIC): a case-control study. Lancet Neurol. 2012;11(9):774–83. · DOI

Cited by

Sorted by citations

See all 36

Metadata

Authors
Wright, C., Wordsworth, R., & Glennie, L.
Affiliations
Meningitis Research Foundation (GB)
Corresponding author
Wright, Claire
Venue
Pediatric Drugs
Published
2013-01-16
Volume
15
Issue
1
Pages
49-58
ISSN
  • 1174-5878 (ISSN-L)
  • 1179-2019
OpenAlex
W25177459
Cited by
36
References
1
Citations by year
2026: 1 · 2025: 1 · 2024: 2 · 2023: 2 · 2022: 1 · 2021: 2 · 2020: 2 · 2019: 6 · 2018: 5 · 2016: 3 · 2015: 4 · 2014: 5 · 2013: 2
FWCI
4.28
Type
journal article
Language
en
Open access
closed
Locations
  • Pediatric Drugs (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Pfizer
  • GlaxoSmithKline
Topics
  • Life Sciences › Immunology and Microbiology › Microbiology › Bacterial Infections and Vaccines
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
  • Physical Sciences › Engineering › Building and Construction › Life Cycle Costing Analysis
Keywords
meningococcal disease, long-term sequelae, cost estimation, meningitis, septicemia, cost-effectiveness, disability, educational costs, social care costs, health care costs, NHS perspective, government perspective
MeSH terms
Analysis of Variance, Cost-Benefit Analysis, Costs and Cost Analysis, United Kingdom, Humans, Meningitis, Meningococcal, Sepsis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Counting the Cost of Meningococcal Disease: Scenarios of Severe Meningitis and Septicemia. https://app.cochat.ai/papers/10.1007/s40272-012-0006-0
The paper
Wright, C., Wordsworth, R., & Glennie, L. (2013). Counting the Cost of Meningococcal Disease: Scenarios of Severe Meningitis and Septicemia. Pediatric Drugs. https://doi.org/10.1007/s40272-012-0006-0